16 Jan, 2020 11:32 AM
Noxopharm (ASX: NOX) announces the listing today on the ASX (ASX: NYR) of its spin-off company, Nyrada Inc (Nyrada).
The IPO Offer was fully subscribed, with A$8.5M being raised.
For mor...read more
20 Dec, 2019 09:04 AM
Noxopharm (NOX:ASX) releases a webinar containing further details on its DARRT-1 study clinical data read-out, along with a commentary from prominent Australian medical oncologist, Professor Paul de...read more
17 Dec, 2019 09:55 AM
The Boards of both Noxopharm Ltd (ASX:NOX) and Nyrada Inc (‘Nyrada’) are pleased to announce that commitments for the Maximum Subscription of $8,500,000 for the Nyrada Initial Public Off...read more
09 Dec, 2019 11:04 AM
Sydney, 9 December 2019: Noxopharm Limited (ASX:NOX) advises that its subsidiary, Nyrada Inc. (Nyrada), has today lodged a supplementary prospectus (Supplementary Prospectus) with ASIC.
The suppl...read more
03 Dec, 2019 02:40 PM
AU$2,400,000 extension of existing convertible security Agreement
Short-term funding earmarked for pharmacokinetic study
SYDNEY, December 3rd, 2019: Noxopharm Ltd (ASX:NOX) i...read more
28 Nov, 2019 09:29 AM
The securities of Noxopharm Limited ('NOX') will be placed in trading halt at the request of NOX, pending it releasing an announcement. Unless ASX decides otherwise, the securities will rema...read more
26 Nov, 2019 05:06 PM
Noxopharm Limited (ASX: NOX) advises that its subsidiary, Nyrada Inc, has today lodged with ASIC a prospectus to raise by issue of Chess Depositary Interests (CDIs) between AU$7 million and AU$8.5 m...read more
20 Nov, 2019 09:13 AM
Noxopharm (ASX: NOX) is pleased to provide shareholders and the market generally the corporate presentations for today’s Annual General Meeting (AGM). Following voting formalities, three prese...read more